Study record

Cortical Electrophysiology of Response Inhibition in Parkinson's Disease

Cortical Electrophysiology of Response Inhibition in Parkinson's Disease

NCT06234995

RecruitingPhase 4

Sponsor: Emory University

Conditions: Parkinson Disease

Interventions: Levodopa, Clinical DBS Setting, Sham DBS, DBS Setting Maximizing Prefrontal Activation, DBS Setting Minimizing Prefrontal Activation

Countries: United States

Patients with Parkinson's Disease will be studied before, during, and after a deep brain stimulation implantation procedure to see if the stimulation location and the size of the electrical field produced by subthalamic nucleus (STN) DBS determine the degree to which DBS engages circuits that involve prefrontal cortex executive functions, and therefore have a direct impact on the patient's ability to inhibit actions.

Study history thread

Detected changes and registry snapshots from Trial Radar syncs

No change history yet

Trial Radar records a thread each time this study syncs from ClinicalTrials.gov. Last registry update: Sep 3, 2026.

View official CT.gov history →

← Back to dashboard